OPPICI, Elisa
 Distribuzione geografica
Continente #
EU - Europa 1.792
NA - Nord America 1.768
AS - Asia 1.358
SA - Sud America 172
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.109
Nazione #
US - Stati Uniti d'America 1.731
RU - Federazione Russa 788
CN - Cina 592
SG - Singapore 460
GB - Regno Unito 365
BR - Brasile 153
IT - Italia 134
HK - Hong Kong 121
SE - Svezia 107
FR - Francia 82
DE - Germania 81
IE - Irlanda 78
VN - Vietnam 75
FI - Finlandia 60
BE - Belgio 22
KR - Corea 22
CA - Canada 21
UA - Ucraina 20
JP - Giappone 19
IN - India 17
ES - Italia 13
PL - Polonia 12
ID - Indonesia 11
NL - Olanda 10
MX - Messico 8
AR - Argentina 7
EC - Ecuador 7
IQ - Iraq 7
TR - Turchia 7
ZA - Sudafrica 6
PK - Pakistan 5
AT - Austria 4
BD - Bangladesh 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
IL - Israele 3
PA - Panama 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CO - Colombia 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
MA - Marocco 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GL - Groenlandia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.109
Città #
Southend 313
Moscow 254
Chandler 251
Dallas 243
Singapore 203
Woodbridge 138
Ann Arbor 132
Ashburn 129
Beijing 120
Hong Kong 120
Jacksonville 106
Dublin 78
Verona 77
Jinan 52
New York 45
The Dalles 42
Houston 39
Nanjing 38
Lawrence 33
Princeton 33
Shenyang 32
Hebei 30
Wilmington 29
Los Angeles 28
Columbus 23
Ho Chi Minh City 23
Tianjin 23
Haikou 21
Brussels 20
São Paulo 20
Zhengzhou 20
Seattle 19
Ningbo 18
Tokyo 18
Changsha 16
Seoul 16
Buffalo 15
Helsinki 15
Munich 15
Santa Clara 15
Nanchang 14
Taizhou 14
Dong Ket 13
Hanoi 13
Guangzhou 12
Hangzhou 12
Lanzhou 12
Montreal 11
Redondo Beach 11
San Francisco 11
Stockholm 11
Boardman 10
Belo Horizonte 9
Council Bluffs 9
Fuzhou 9
Jakarta 9
Jiaxing 9
Taiyuan 9
Brooklyn 8
Milan 8
Warsaw 8
Denver 7
Kent 7
Norwalk 7
Amsterdam 6
London 6
Phoenix 6
Redwood City 6
Boston 5
Chennai 5
Dearborn 5
Redmond 5
Atlanta 4
Cagliari 4
Falkenstein 4
Frankfurt am Main 4
Lancaster 4
Orem 4
Perugia 4
Qingdao 4
Rio de Janeiro 4
Riva 4
Auburn Hills 3
Baghdad 3
Caserta 3
Chicago 3
Detroit 3
Falls Church 3
Fortaleza 3
Hyderabad 3
Johannesburg 3
Kemerovo 3
Madrid 3
Mumbai 3
Nuremberg 3
Poplar 3
Quito 3
Santo André 3
Toronto 3
Baku 2
Totale 3.242
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 256
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 235
Molecular and cellular insights into defects of human alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I 196
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 188
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 180
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 178
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 177
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 176
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 173
Folding defects leading to primary hyperoxaluria 173
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 169
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 168
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 165
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 162
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 155
Dimerization drives proper folding of human Alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 154
Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia 152
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 149
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 149
Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6 146
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 146
Evolutionary divergent suppressor mutations in conformational diseases 143
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 141
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 139
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 139
Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from Bacillus Subtilis at neutral pH 137
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 127
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 125
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 124
Molecular basis of primary hyperoxaluria: clues to innovative treatments 121
A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors 118
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 105
Molecular insights into primary hyperoxaluria Type I pathogenesis. 102
Totale 5.168
Categoria #
all - tutte 16.132
article - articoli 14.499
book - libri 0
conference - conferenze 629
curatela - curatele 0
other - altro 502
patent - brevetti 0
selected - selezionate 0
volume - volumi 502
Totale 32.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 20 8 10 5 6 35 24
2021/2022339 28 142 28 9 7 3 6 20 16 8 12 60
2022/2023660 40 88 54 118 62 135 15 41 70 1 21 15
2023/2024262 16 13 11 15 30 50 5 35 5 15 48 19
2024/2025842 41 49 22 138 69 31 66 29 150 51 74 122
2025/20261.715 176 95 285 370 685 104 0 0 0 0 0 0
Totale 5.168